Kim IA - Search Results

1

Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6.

Kim IA, No M, Lee JM, Shin JH, Oh JS, Choi EJ, Kim IH, Atadja P, Bernhard EJ. Kim IA, et al. Among authors: kim ih. Radiother Oncol. 2009 Jul;92(1):125-32. doi: 10.1016/j.radonc.2009.03.008. Epub 2009 Mar 28. Radiother Oncol. 2009. PMID: 19329208

2

Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin.

Li B, Yuan M, Kim IA, Chang CM, Bernhard EJ, Shu HK. Li B, et al. Among authors: kim ia. Oncogene. 2004 Jun 3;23(26):4594-602. doi: 10.1038/sj.onc.1207602. Oncogene. 2004. PMID: 15077177

3

The influence of Ras pathway signaling on tumor radiosensitivity.

Kim IA, Fernandes AT, Gupta AK, McKenna WG, Bernhard EJ. Kim IA, et al. Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):227-36. doi: 10.1023/B:CANC.0000031763.95152.09. Cancer Metastasis Rev. 2004. PMID: 15197325 Review.

4

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.

Kim IA, Bae SS, Fernandes A, Wu J, Muschel RJ, McKenna WG, Birnbaum MJ, Bernhard EJ. Kim IA, et al. Cancer Res. 2005 Sep 1;65(17):7902-10. doi: 10.1158/0008-5472.CAN-05-0513. Cancer Res. 2005. PMID: 16140961

5

Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.

Kim IA, Shin JH, Kim IH, Kim JH, Kim JS, Wu HG, Chie EK, Ha SW, Park CI, Kao GD. Kim IA, et al. Among authors: kim ih, kim js, kim jh. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):940-9. doi: 10.1158/1078-0432.CCR-05-1230. Clin Cancer Res. 2006. PMID: 16467109

6

Targeting HER2 signaling pathway for radiosensitization: alternative strategy for therapeutic resistance.

No M, Choi EJ, Kim IA. No M, et al. Among authors: kim ia. Cancer Biol Ther. 2009 Dec;8(24):2351-61. doi: 10.4161/cbt.8.24.10131. Epub 2009 Dec 19. Cancer Biol Ther. 2009. PMID: 19923913 Free article.

7

A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.

Kim IA, Kim JH, Shin JH, Kim IH, Kim JS, Wu HG, Chie EK, Kim YH, Kim BK, Hong S, Park SW, Ha SW, Park CI. Kim IA, et al. Among authors: kim ih, kim yh, kim js, kim bk, kim jh. Cancer Res Treat. 2005 Apr;37(2):122-8. doi: 10.4143/crt.2005.37.2.122. Epub 2005 Apr 30. Cancer Res Treat. 2005. PMID: 19956491 Free PMC article.

8

Enhancement of radiation effects by flavopiridol in uterine cervix cancer cells.

Kim S, Wu HG, Shin JH, Park HJ, Kim IA, Kim IH. Kim S, et al. Among authors: kim ih, kim ia. Cancer Res Treat. 2005 Jun;37(3):191-5. doi: 10.4143/crt.2005.37.3.191. Epub 2005 Jun 30. Cancer Res Treat. 2005. PMID: 19956502 Free PMC article.

9

A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.

Kim CY, Kim SK, Phi JH, Lee MM, Kim IA, Kim IH, Wang KC, Jung HL, Lee MJ, Cho BK. Kim CY, et al. Among authors: kim ih, kim sk, kim ia. J Neurooncol. 2010 Nov;100(2):193-8. doi: 10.1007/s11060-010-0157-1. Epub 2010 Mar 23. J Neurooncol. 2010. PMID: 20309719 Clinical Trial.

10

HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon?

Kim IA, Kim IH, Kim HJ, Chie EK, Kim JS. Kim IA, et al. Among authors: kim ih, kim hj, kim js. J Radiat Res. 2010;51(3):257-63. doi: 10.1269/jrr.09115. J Radiat Res. 2010. PMID: 20505264 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters